Drug recall · July 25, 2012
Ciprofloxacin Tablets recall
Why: Labeling Illegible: Missing Label; The voluntary recall of the aforementioned batch of product is being initiated due to two bottles missing container labels.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Ciprofloxacin Tablets, USP, 500 mg, Rx Only, 100 Tablets per Bottle, Manufactured in India by: Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai - 400 030, Distributed by: PACK Pharmaceuticals, LLC, Buffalo Grove, IL 60089, NDC 16571-412-10.
- Lots / codes
Lot #: : PUB1040, Exp 08/2015
- Quantity
- 4,848 bottles
- Company
- Pack Pharmaceuticals, Buffalo Grove, IL
- Distribution
- Nationwide
- Initiated
- March 9, 2012 · Voluntary: Firm initiated
- Classified
- July 19, 2012
- Reported
- July 25, 2012
- Ended
- July 19, 2012
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ciprofloxacin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.